Schedule 13G ownership disclosure
Fennec Pharmaceuticals Inc
Security class unavailable · CUSIP: 31447P100
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,105,999
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-18-000890
- Form type
- SC 13G
- Filer
- FENNEC PHARMACEUTICALS INC.
- CIK
- CIK 1211583
- Filed
- Feb 12, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership